QA: Athenex Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001300699_2022_Athenex_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001300699, Athenex Inc

  xvar xval
0 AssetsCurrent 133,396,000
1 IntangibleAssetsNetIncludingGoodwill 71,896,000
2 PropertyPlantAndEquipmentNet 27,978,000
3 remainder_Assets 34,178,000
4 LiabilitiesCurrent 96,047,000
5 LiabilitiesNoncurrent 7,540,000
6 remainder_Liabilities 129,409,000
7 CostOfGoodsAndServicesSold 82,406,000
8 SellingGeneralAndAdministrativeExpense 72,553,000
9 ResearchAndDevelopmentExpense 80,197,000
10 remainder_Expenses 79,557,000
11 remainder_Revenues 120,181,000
12 remainder_NetIncome -7,504,000
13 remainder_ComprehensiveNetIncome 2,915,000
  yvar yval
0 Assets 267,448,000
1 Liabilities 232,996,000
2 Expenses 314,713,000
3 Revenues 120,181,000
4 StockholdersEquity 34,452,000
5 NetIncome -202,036,000
6 ComprehensiveNetIncome -200,578,500
7 BaseVar 472,878,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.501
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution